about
Long-term follow-up of laparoscopic splenectomy in patients with immune thrombocytopenic purpuraThe RON receptor tyrosine kinase in pancreatic cancer pathogenesis and its potential implications for future targeted therapiesRobotic total mesorectal excision for the treatment of rectal cancer.The first experiences of robotic single-site cholecystectomy in Asia: a potential way to expand minimally-invasive single-site surgery?Robotic pylorus preserving pancreaticoduodenectomy with mini-laparotomy reconstruction in patient with ampullary adenoma.Pathophysiology after pancreaticoduodenectomy.Transumbilical single port laparoscopic adrenalectomy: a technical report on right and left adrenalectomy using the glove port.Serous cyst adenoma of the pancreas: appraisal of active surgical strategy before it causes problems.Revisiting vascular patency after spleen-preserving laparoscopic distal pancreatectomy with conservation of splenic vesselsRisk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic CancerExposure of surgeons to extremely low-frequency magnetic fields during laparoscopic and robotic surgeries.The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular InvolvementOverestimated Oncologic Significance of Lymph Node Metastasis in G1 Nonfunctioning Neuroendocrine Tumor in the Left Side of the Pancreas.Single-Site Robotic Cholecystectomy: Reverse-Port TechniqueClinically determined type of 18F-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer.Preoperative Volume-Based PET Parameter, MTV2.5, as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer.The first korean experience of telemanipulative robot-assisted laparoscopic cholecystectomy using the da vinci system.Identification of an N staging system that predicts oncologic outcome in resected left-sided pancreatic cancerPreoperative defining system for pancreatic head cancer considering surgical resection.Maximum Standard Uptake Value as a Clinical Biomarker for Detecting Loss of SMAD4 Expression and Early Systemic Tumor Recurrence in Resected Left-Sided Pancreatic Cancer.Acute chylous peritonitis mimicking ovarian torsion in a patient with advanced gastric carcinoma.Single-fulcrum laparoscopic cholecystectomy in uncomplicated gallbladder diseases: a retrospective comparative analysis with conventional laparoscopic cholecystectomyPrognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer.Clinical necessity of the immunohistochemical reassessment of para-aortic lymph nodes in resected pancreatic ductal adenocarcinoma.Effects of neoadjuvant combined chemotherapy and radiation therapy on the CT evaluation of resectability and staging in patients with pancreatic head cancer.Minimally invasive radical pancreatectomy for left-sided pancreatic cancer: current status and future perspectives.Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles.Negative oncologic impact of poor postoperative pain control in left-sided pancreatic cancer.Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer.Minimally invasive central pancreatectomy: current status and future directions.Laparoscopic pancreatic reconstruction technique following laparoscopic pancreaticoduodenectomy.Normal Postoperative Computed Tomography Findings after a Variety of Pancreatic SurgeriesRobotic single-site plus ONE port distal pancreatectomy.Predicting recurrence of pancreatic solid pseudopapillary tumors after surgical resection: a multicenter analysis in Korea.Minimally Invasive Approach for Spleen-Preserving Distal Pancreatectomy: a Comparative Analysis of Postoperative Complication Between Splenic Vessel Conserving and Warshaw's Technique.Molecular mechanisms of cell death of mycophenolic acid-treated primary isolated rat islets: implication of mitogen-activated protein kinase activation.Hepatoid carcinoma of the pancreas combined with neuroendocrine carcinoma.Adverse oncologic effects of intraoperative transfusion during pancreatectomy for left-sided pancreatic cancer: the need for strict transfusion policy.Pancreas club international joint symposium on pancreatic cancer 2012, Kyoto: down staging chemo±radiotherapy for borderline resectable pancreatic cancer.Distinct Protein Expression Profiles of Solid-Pseudopapillary Neoplasms of the Pancreas.
P50
Q33375708-B76F7096-9317-430F-BB4E-FB236C96CB1CQ33563635-0DB7094B-E187-4200-9F9C-6B065CFE1106Q34586023-54A28EDA-52D2-4D5D-8BBD-62EC1E7A7D05Q34774139-95F1C5A4-0EBD-4F26-8780-3EDB7F12F614Q35587613-19DC8195-8E70-47CE-BA75-7484979763D5Q35625352-D0CCFB58-4979-49D0-9291-811B155161EBQ35767409-2D59FB54-7603-491A-8916-3856412D3062Q35957587-4E2C761A-32B3-438F-BB5B-E17E057D291BQ35957607-0E742D51-4D73-46E6-BB74-070002E6F21FQ36058855-8CED80E7-0699-4944-963A-9BC15F3F57AEQ36152374-7FC38BFA-23C9-4D0D-B98F-4E013756D6B5Q36194657-CDD89A34-0548-4E78-A700-BCCBD6FF246DQ36194989-5E0139D8-63F8-490D-96FF-020DBA97A369Q36206992-D29A92E4-B174-4E7B-AC1C-9C9200FDBAECQ36290046-40A40B92-28DE-4211-977A-8FE647C14079Q36663805-E5FC628A-0F0B-4634-BF3A-2052E59FD423Q37065457-2EA548B7-169A-4251-8427-04E936656779Q37078023-F397F10A-3AF4-4EA3-BD63-AC37FAFF6BE1Q37102218-AD690158-68A0-4096-A1D1-8797DAF16105Q37206394-D82769EB-E757-4347-8EF7-E85F45C8288EQ37222483-989617A6-79A9-44E5-8245-078692037DC9Q37259477-09C0CB9C-2D41-4DD4-B6D1-68E4030EA623Q37259570-C7C83207-9A83-4913-AB8E-F68C9CD17B02Q37269610-A435BC18-EA95-4E90-8992-3DE64E9E9F9DQ37375526-C8BA5F3C-CF40-4457-8041-02FE4683AD0FQ37617974-4C9BD9EA-48B4-424F-B661-6B4C6120EF62Q37624171-4D7A47C6-2604-4148-BE74-0314E15782F6Q37625229-4AD47024-DA93-4644-BEA8-4CA282B606EDQ38091839-F3110B41-73A5-46FF-AF73-0B8888D163B2Q38243061-A9DECC71-29BA-4364-B0D0-CA393535AD79Q38302518-AC144395-EEE9-4B4E-BC7E-79CBCB46D52EQ39155360-5DC3B87C-4DA6-44A2-A21A-6A4222F0188BQ39200146-7BC98C4A-3D79-4B81-9982-0B8AAFAD325AQ39207831-46C4A87A-889D-4074-B7DE-9006950C0569Q39855014-F3CC997C-EEEB-4EAE-BE62-7A0B5501A34AQ39928149-591E9957-7D95-434C-B565-95542EB4A3F7Q40606476-84B62131-5094-459E-8282-BCAD8CAE2BC9Q40703961-A0CB406C-A809-4FE3-BE9E-1B4B38944672Q40758068-94D3B9D3-8F32-4CF7-89CB-4CF8289F7165Q40764181-B9269B58-D52D-451A-AB6D-7DF95747967D
P50
description
researcher ORCID ID = 0000-0002-5382-4658
@en
wetenschapper
@nl
name
Chang Moo Kang
@ast
Chang Moo Kang
@en
Chang Moo Kang
@es
Chang Moo Kang
@nl
type
label
Chang Moo Kang
@ast
Chang Moo Kang
@en
Chang Moo Kang
@es
Chang Moo Kang
@nl
prefLabel
Chang Moo Kang
@ast
Chang Moo Kang
@en
Chang Moo Kang
@es
Chang Moo Kang
@nl
P31
P496
0000-0002-5382-4658